Tandem Diabetes Care Inc (TNDM):企業の財務・戦略的SWOT分析

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME45129FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company’s product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Australia, Italy, New Zealand, and other Scandinavia regions (Sweden, Norway and Denmark). Tandem is headquartered in San Diego, California, the US.

Tandem Diabetes Care Inc Key Recent Developments

Apr 06,2021: Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021
Mar 01,2021: Tandem Diabetes Care appoints leading artificial pancreas researcher Dr. Jordan Pinsker as medical director
Feb 24,2021: Tandem Diabetes Care announces fourth quarter and full year 2020 financial results and 2021 financial guidance
Feb 16,2021: Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

This comprehensive SWOT profile of Tandem Diabetes Care Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tandem Diabetes Care Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tandem Diabetes Care Inc – Key Information
Tandem Diabetes Care Inc – Overview
Tandem Diabetes Care Inc – Key Employees
Tandem Diabetes Care Inc – Key Employee Biographies
Tandem Diabetes Care Inc – Key Operational Heads
Tandem Diabetes Care Inc – Major Products and Services
Tandem Diabetes Care Inc – History
Tandem Diabetes Care Inc – Company Statement
Tandem Diabetes Care Inc – Locations And Subsidiaries
Tandem Diabetes Care Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tandem Diabetes Care Inc – Business Description
Tandem Diabetes Care Inc – Corporate Strategy
Tandem Diabetes Care Inc – SWOT Analysis
SWOT Analysis – Overview
Tandem Diabetes Care Inc – Strengths
Tandem Diabetes Care Inc – Weaknesses
Tandem Diabetes Care Inc – Opportunities
Tandem Diabetes Care Inc – Threats
Tandem Diabetes Care Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Tandem Diabetes Care Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tandem Diabetes Care Inc, Key Information
Tandem Diabetes Care Inc, Key Ratios
Tandem Diabetes Care Inc, Share Data
Tandem Diabetes Care Inc, Major Products and Services
Tandem Diabetes Care Inc, History
Tandem Diabetes Care Inc, Key Employees
Tandem Diabetes Care Inc, Key Employee Biographies
Tandem Diabetes Care Inc, Key Operational Heads
Tandem Diabetes Care Inc, Other Locations
Tandem Diabetes Care Inc, Subsidiaries
Tandem Diabetes Care Inc, Key Competitors
Tandem Diabetes Care Inc, SWOT Analysis
Tandem Diabetes Care Inc, Ratios based on current share price
Tandem Diabetes Care Inc, Annual Ratios
Tandem Diabetes Care Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • Tidewater Midstream and Infrastructure Ltd (TWM):石油・ガス:M&Aディール及び事業提携情報
    Summary Tidewater Midstream and Infrastructure Ltd (Tidewater Midstream) is a midstream and infrastructure company. It is involved in purchasing, sale and transportation of NGLs and export to overseas markets. The company engaged in selective acquisitions, organic growth projects, and optimization o …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Spire, Inc.:戦略・SWOT・企業財務分析
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NV Bekaert SA:戦略・SWOT・企業財務分析
    NV Bekaert SA - Strategy, SWOT and Corporate Finance Report Summary NV Bekaert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Living Cell Technologies Ltd (LCT):医療機器:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preserva …
  • Sabre Corporation:企業の戦略・SWOT・財務分析
    Sabre Corporation - Strategy, SWOT and Corporate Finance Report Summary Sabre Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nature’s Sunshine Products Inc (NATR):企業の財務・戦略的SWOT分析
    Summary Nature's Sunshine Products Inc (Nature's Sunshine) is a manufacturer and marketer of nutritional and personal care products. The company’s products comprise daily essential pack, probiotics, antioxidants, enzymes, vitamins and minerals, general cleansers, fiber, meal replacement and protein, …
  • Mari Petroleum Co Ltd (MARI):石油・ガス:M&Aディール及び事業提携情報
    Summary Mari Petroleum Co Ltd (MPCL) is an integrated exploration and production company. It carries out exploration and production of crude oil, natural gas, condensate and liquefied petroleum gas (LPG). The company operates through exploration and production assets across four provinces in Pakista …
  • GE Healthcare LLC:医療機器:M&Aディール及び事業提携情報
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Strukton Groep NV:企業の戦略・SWOT・財務情報
    Strukton Groep NV - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Parenteral Drug India Ltd (PDPL):企業の財務・戦略的SWOT分析
    Summary Parenteral Drug India Ltd (PDIL) is a healthcare company that manufactures pharmaceutical products. The company provides products such as solid and liquid orals, IV fluids, oncology products and anaesthesia products. It offers IV fluids such as carbohyrated and electrolytes; diuretics, dialy …
  • RELX Group plc:企業の戦略・SWOT・財務情報
    RELX Group plc - Strategy, SWOT and Corporate Finance Report Summary RELX Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bharti Infratel Ltd
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tsakos Energy Navigation Ltd (TNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tsakos Energy Navigation Ltd (TEN), a subsidiary of Tsakos Group, is a marine transportation company that provides transportation services of crude oil, petroleum products and liquefied natural gas (LNG) to national and international oil companies and refineries. It charges customer on time …
  • Empresa Nacional del Petroleo:企業の戦略的SWOT分析
    Empresa Nacional del Petroleo - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Simona AG (SIM):企業の財務・戦略的SWOT分析
    Summary Simona AG (Simona) is a chemical company that manufactures and distributes chemicals and thermoplastic products. The company offers products such as pipes and fittings, semi-finished products, and finished parts, among others. Its semi-finished plastics include profiles, plates, rods, and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆